RAPT Therapeutics, Inc. (RAPT) Return on Equity (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Return on Equity for 5 consecutive years, with 1.12% as the latest value for Q3 2024.
- Quarterly Return on Equity fell 49.0% to 1.12% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 1.12% through Sep 2024, down 49.0% year-over-year, with the annual reading at 0.65% for FY2023, 25.0% down from the prior year.
- Return on Equity hit 1.12% in Q3 2024 for RAPT Therapeutics, down from 1.07% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.31% in Q3 2021 to a low of 1.12% in Q3 2024.
- Historically, Return on Equity has averaged 0.57% across 5 years, with a median of 0.45% in 2023.
- Biggest five-year swings in Return on Equity: grew 18bps in 2022 and later crashed -57bps in 2024.
- Year by year, Return on Equity stood at 0.49% in 2020, then surged by 31bps to 0.34% in 2021, then dropped by -15bps to 0.39% in 2022, then plummeted by -101bps to 0.79% in 2023, then plummeted by -41bps to 1.12% in 2024.
- Business Quant data shows Return on Equity for RAPT at 1.12% in Q3 2024, 1.07% in Q2 2024, and 0.92% in Q1 2024.